Zurück zu Projekte

19205.1 PFLS-LS

Discovery & development of novel cancer immunotherapeutics

Zusammenfassung

Discovery & development of novel cancer immunotherapeutics

Weitere Texte

Abstract

Boosting tumor-directed immune responses by inhibiting tumor evasion mechanisms bears significant therapeutic promise. Although unprecedented clinical success has been achieved by blockade of immune checkpoint pathways, these therapies still have only partial efficacy. Our goal is to develop first-in-class neutralising monoclonal antibodies against a novel immune checkpoint regulator that we have identified, with the aim of strengthening antitumor immunity in cancer patients.

Beteiligte

Walter Reith

Kontaktperson

walter.reith@unige.ch

Université de Genève Walter Reith Rue Michel Servet 1 1211 Genève GE CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2016-08-31
Enddatum
2018-02-28
Bewilligte Gesamtkosten
CHF 332545.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Industrielle Produktivität und Technologie

Forschungsdisziplinen

  • T490 Biotechnology 100.0%